Literature DB >> 7061990

Monoclonal antibodies against the flavivirus West Nile.

J S Peiris, J S Porterfield, J T Roehrig.   

Abstract

Monoclonal antibodies having three different specificities have been prepared against the Egypt 101 strain of West Nile virus (WNV). All were reactive against the envelope glycoprotein in radioimmune precipitation tests, and all enhanced WNV replication in the mouse macrophage line P388D1. One antibody, which is of IgG2a subclass, had strong neutralizing activity against the homologous virus, although it failed to neutralize a different WNV strain. The other two antibodies, both of IgG1 subclass, had little neutralizing activity, but one had strong reactivity with the haemagglutinin of the inducing virus and other flavivirus haemagglutinins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061990     DOI: 10.1099/0022-1317-58-2-283

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

Review 1.  Insights into neutralization of animal viruses gained from study of influenza virus.

Authors:  M C Outlaw; N J Dimmock
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

2.  Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds.

Authors:  Ryo Murata; Yuki Eshita; Akihiko Maeda; Junko Maeda; Saki Akita; Tomohisa Tanaka; Kentaro Yoshii; Hiroaki Kariwa; Takashi Umemura; Ikuo Takashima
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Detection of rotavirus by a latex agglutination test, Rotalex: comparison with electron microscopy, immunofluorescence, polyacrylamide gel electrophoresis, and enzyme linked immunosorbent assay.

Authors:  R B Moosai; R Alcock; T M Bell; F R Laidler; J S Peiris; A P Wyn-Jones; C R Madeley
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

4.  Antigenic analysis of West Nile virus strains using monoclonal antibodies.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

6.  Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies.

Authors:  J Kimura-Kuroda; K Yasui
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

7.  Immunological enhancement and the pathogenesis of dengue haemorrhagic fever.

Authors:  J S Porterfield
Journal:  J Hyg (Lond)       Date:  1982-12

8.  Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.

Authors:  W A Boere; B J Benaissa-Trouw; T Harmsen; T Erich; C A Kraaijeveld; H Snippe
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

9.  Introduction of West Nile virus in the Middle East by migrating white storks.

Authors:  Mertyn Malkinson; Caroline Banet; Yoram Weisman; Shimon Pokamunski; Roni King; Marie-Thérèse Drouet; Vincent Deubel
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

10.  Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Authors:  Soila Sukupolvi-Petty; S Kyle Austin; Whitney E Purtha; Theodore Oliphant; Grant E Nybakken; Jacob J Schlesinger; John T Roehrig; Gregory D Gromowski; Alan D Barrett; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.